Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Study of the Safety and Efficacy of Hematide Injection for the Maintenance Treatment of Anemia in Peritoneal Dialysis Subjects Previously Treated With Epoetin

NCT00752791 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT00752791
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00752791 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Study of the Safety and Efficacy of Hematide Injection for the Maintenance Treatment of Anemia in Peritoneal Dialysis Subjects Previously Treated With Epoetin
Lead sponsor
Takeda
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2008
Completion date
May 31, 2010
Enrollment
59 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

anemia